Unknown

Dataset Information

0

Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States.

ABSTRACT: There are currently hundreds of businesses across the United States offering direct-to-consumer stem cell treatments that have not been through regulatory approval by the Food and Drug Administration (FDA). Here, we provide a detailed characterization of nearly 170 stem cell businesses operating in the Southwest United States. We draw specific attention to two as-yet understudied facets of these businesses. First, we identify differences in the degree to which a given business focuses their practice on stem cell treatments. Second, we compare the stated expertise of the care providers in stem cell businesses with the range of conditions they purport to treat. These findings deepen our knowledge of the growing industry around unapproved stem cell treatments, and are used here to offer suggestions for how the FDA might target its resources with respect to regulatory oversight.

SUBMITTER: Frow EK 

PROVIDER: S-EPMC6700498 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States.

Frow Emma K EK   Brafman David A DA   Muldoon Anna A   Krum Logan L   Williams Paige P   Becker Bryson B   Nelson John P JP   Pritchett Ashley A  

Stem cell reports 20190801 2

There are currently hundreds of businesses across the United States offering direct-to-consumer stem cell treatments that have not been through regulatory approval by the Food and Drug Administration (FDA). Here, we provide a detailed characterization of nearly 170 stem cell businesses operating in the Southwest United States. We draw specific attention to two as-yet understudied facets of these businesses. First, we identify differences in the degree to which a given business focuses their prac  ...[more]

Similar Datasets

Unknown Weighing up the evidence used by direct-to-consumer stem cell businesses.
| S-EPMC8693621 | biostudies-literature
Unknown Effect of Direct-to-Consumer Advertising on Statin Use in the United States.
| S-EPMC5642991 | biostudies-literature
Unknown Profiles of total worker health® in United States small businesses.
| S-EPMC8164062 | biostudies-literature
Unknown Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013.
| S-EPMC5471355 | biostudies-literature
Unknown Characterization of gut microbiomes of household pets in the United States using a direct-to-consumer approach.
| S-EPMC7032713 | biostudies-literature
Unknown Effects of Televised Direct-to-Consumer Advertising for Varenicline on Prescription Dispensing in the United States, 2006-2009.
| S-EPMC6407843 | biostudies-literature
Unknown Characterizing HIV transmission networks across the United States.
| S-EPMC3529609 | biostudies-literature
Unknown Characterizing Norovirus Transmission from Outbreak Data, United States.
| S-EPMC7392428 | biostudies-literature
Unknown Kissing Bug Intrusions into Homes in the Southwest United States.
| S-EPMC8306929 | biostudies-literature
Unknown Characterizing SARS-CoV-2 mutations in the United States.
| S-EPMC7430589 | biostudies-literature